Literature DB >> 16387710

Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761.

Anne Eckert1, Uta Keil, Isabel Scherping, Susanne Hauptmann, Walter E Müller.   

Abstract

Ginkgo biloba extract EGb 761 has been used for many years to treat age-related cognitive disorders including Alzheimer's disease. EGb 761 given shortly after initiating mitochondrial damage by sodium nitroprusside (nitric oxide donor) improved the mitochondrial membrane potential of PC12 cells significantly and dose dependently. Under these conditions, EGb 761 also reversed the decrease in ATP production. In addition, similar protection against oxidative damage was found in dissociated brain cells and isolated brain mitochondria after in vitro or in vivo treatment with EGb 761. Moreover, PC12 cells bearing an Alzheimer's disease-related mutation in the amyloid precursor protein, which leads to enhanced beta amyloid production, showed greater benefit from treatment with EGb 761 than did control cells. Taken together, our findings clearly show stabilization and protection of mitochondrial function as a specific and very sensitive property of EGb 761 at therapeutically relevant doses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16387710     DOI: 10.1196/annals.1352.023

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  44 in total

1.  Effects of Ginkgo biloba extract on heart and liver mitochondrial functions: mechanism(s) of action.

Authors:  Giedre Baliutyte; Rasa Baniene; Sonata Trumbeckaite; Vilmante Borutaite; Adolfas Toleikis
Journal:  J Bioenerg Biomembr       Date:  2010-03-19       Impact factor: 2.945

2.  Effects of Gingko Extract (EGb761) on oxidative damage under different conditions of serum supply.

Authors:  Chun Shi; Zhibing Yao; Jie Xu; David T Yew
Journal:  J Bioenerg Biomembr       Date:  2009-02-11       Impact factor: 2.945

3.  Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma.

Authors:  Seong Hee Shim; Joon Mo Kim; Chul Young Choi; Chan Yun Kim; Ki Ho Park
Journal:  J Med Food       Date:  2012-08-07       Impact factor: 2.786

4.  Effects of standardized extract of Ginkgo biloba leaves EGb761 on mitochondrial functions: mechanism(s) of action and dependence on the source of mitochondria and respiratory substrate.

Authors:  Giedre Baliutyte; Sonata Trumbeckaite; Rasa Baniene; Vilmante Borutaite; Adolfas Toleikis
Journal:  J Bioenerg Biomembr       Date:  2014-11-14       Impact factor: 2.945

5.  Centella asiatica Attenuates Amyloid-β-Induced Oxidative Stress and Mitochondrial Dysfunction.

Authors:  Nora E Gray; Harini Sampath; Jonathan A Zweig; Joseph F Quinn; Amala Soumyanath
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 6.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

Review 7.  Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Authors:  Sandeep Kumar Singh; Saurabh Srivastav; Rudolph J Castellani; Germán Plascencia-Villa; George Perry
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 8.  Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.

Authors:  Anne Eckert; Kathrin L Schulz; Virginie Rhein; Jürgen Götz
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

Review 9.  Effects of Ginkgo biloba in dementia: systematic review and meta-analysis.

Authors:  Stefan Weinmann; Stephanie Roll; Christoph Schwarzbach; Christoph Vauth; Stefan N Willich
Journal:  BMC Geriatr       Date:  2010-03-17       Impact factor: 3.921

Review 10.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.